Carregant...
Treatment of unresectable cutaneous squamous cell carcinoma with pembrolizumab
Currently, there are few effective therapies for locally advanced and metastatic cutaneous squamous cell carcinoma (cSCC); however, there is recent evidence supporting the use of immunological therapies in cSCC given the typically high mutation burden and association with immunosuppressed states. Th...
Guardat en:
| Publicat a: | BMJ Case Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6685369/ https://ncbi.nlm.nih.gov/pubmed/31377718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-229915 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|